Oncology experts believe unlocking the cure for kidney cancer leads to breakthrough treatments for other cancers.
vision
We are committed to curing kidney cancer and other cancers now.
Mission
We are the voice of kidney cancer advocacy in Washington, D.C. and the U.S.
strategy
We seek research funding for breakthroughs and early detection.
opportunities
We welcome you and your advocacy. With relentless devotion to our vision and our shared resources, we will achieve lasting legacies.
WHAT WE'RE DOING
HOW WE'RE DOING IT
Congressional meetings, (in district and in D.C.)
Advocacy days (fly-in) - Capitol Hill
Congressional briefings
Congressional letters
Agency meetings (FDA, NIH/NCI, CDC)
Consortium involvement and engagement (AUA, OVAC, DHRC, AACR, ASCO, SBUR, others)
Convene Stakeholder gatherings - “Connect, Network and Advocate” (attendees – patients, caregivers, physicians, hospitals, industry/pharma, life sciences, others)
Coalition building – IKCC, KCCure, Kure It, OVAC, VHL, JNF, DHRC – Harnessing and leveraging ourresources to have the strongest voice
State leadership activities – Identify, train, activate state ‘grass top’ leaders and advocates.
Stakeholder Registry – database development of grassroots advocates
Public relations/media outreach
Targeted issue advertising
Engaging stakeholders in Washington
Mobilizing the community
Leveraging resources to achieve the vision of a cure
Increased research funding at the NIH/NCI
Increased research funding via the CDMRP
CDC funding for kidney cancer awareness and future screening funding
Congressional information resource
